Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Mass Spectrom Rev. 2022 Dec 16;43(4):683–712. doi: 10.1002/mas.21826

Figure 1:

Figure 1:

Schematic illustration of factors leading to alteration of the body’s biology giving rise to metabolites and disease biomarkers which are the targets of current mass spectrometric screening and diagnostic platforms along with a collection of pre-analytical factors affecting disease screening and diagnosis, thus demanding highly sensitive and accurate methods.